InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Culley Brian M, Président et CEO. Officer active across 1 companies, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 9 reports have been published. Total volume traded: €7k. The latest transaction was disclosed on 25 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
15,450 shares
Common Shares, no par value
SEC:0001493152-22-018271:0·
15,450 shares
Common Shares, no par value
SEC:0001493152-22-009000:0·
€6,5815,250 shares@ €1.25350.0016% mcap1.9% of flow
Common Shares, no par value
SEC:0001493152-22-007925:0·
Ideal exit: 20 Dec 2022 (T+270)
15,450 shares
Common Shares, no par value
SEC:0001493152-22-000116·
15,450 shares
Common Shares, no par value
SEC:0001493152-22-000116:0·
15,450 shares
Common Shares, no par value
SEC:0001493152-21-025197·
15,450 shares
Common Shares, no par value
SEC:0001493152-21-025197:0·
€174,006300,000 shares@ €0.58100.0% of flow
Common Shares, no par value
SEC:0001493152-21-015778·
€174,006300,000 shares@ €0.580.043% mcap49.1% of flow
Common Shares, no par value
SEC:0001493152-21-015778:0·
9 of 9 declarations
About Culley Brian M
Brian M. Culley is President and CEO at Lineage Cell Therapeutics, Inc. He is responsible for the overall direction and strategy of the company. His role is essential in guiding Lineage in its initiatives and ensuring its growth.
